FDA approves atezolizumab for stage II to IIIA lung cancer

October 15, 2021

Posted in In the NewsTagged #fdaapprovals, #inthenews, FDA

FDA approves mobocertinib for EGFR exon 20 insertion+ NSCLC

September 16, 2021

Posted in In the News, ResearchTagged #fdaapprovals, EGFR, FDA

Findings and developments in the lung cancer space during the first half of 2021

August 26, 2021

Posted in In the News, ResearchTagged FDA, Research

Together Separately: 2020 FDA approvals

June 14, 2020

Posted in EducationTagged #fdaapprovals, FDA, togetherseparately

Approval of Keytruda Every Six Weeks a ‘Welcome Change’ for Patients With Cancer

May 31, 2020

Posted in In the News, ResearchTagged #fdaapprovals, FDA

FDA announcements speak to urgency of improving lung cancer treatment

May 12, 2020

Posted in In the News, ResearchTagged #fdaapprovals, FDA

New targeted therapy approved

August 16, 2019

Posted in In the News, ResearchTagged #fdaapprovals, FDA

FDA approves pembrolizumab for second or third-line treatment of metastatic small cell lung cancer

July 2, 2019

Posted in In the News, SCLCTagged #fdaapprovals, FDA, SCLC

FDA Approves Pembrolizumab for First-Line Treatment of Stage III NSCLC

April 12, 2019

Posted in In the NewsTagged #fdaapprovals, FDA